Caris Life Sciences, Inc.
CAIBiotechnology
$36.14+1.95%As of Oct 29vs prior close
- Market cap
- $10.2B
- P/E (TTM)
- 4.3×
- P/E (FY1)
- 261.9×
- From 52W high
- 0.00%
- EPS (LTM)
- $8.32
- Revenue (LTM)
- $989.6M
- Net margin
- 10.62%
- Dividend yield
- 0.00%
Nomior Score
51
Steady ProfileTop 48% of the scored universe
Growth52
Quality70
Value50
Momentum46
Resilience38
Growth
+62.87%revenue a year over 2 fiscal years
YE23 $306.1MLTM $989.6M
Connections
Revenue to profitQ2 FY26
The net loss was 0% of revenue, narrower by 39 pts on a year.
Who owns it
1fund, 2 tracked portfolios